Epidemiology of HIV infection in Lebanon: Data from 1985-2005

Journal Medical Libanais

Volumn 54, Issue 2, 2006, Pages 61-64

  Traboulsi, Rana ^a   Kanafani, Zeina A ^b   Nakib, Mustapha ^c   Kanj, Souha S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c National Lebanese AIDS Control Program   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

BLOOD TRANSFUSION; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG USE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEBANON; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH BEHAVIOR; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LEBANON; MALE; MIDDLE AGED; PREVALENCE; RISK-TAKING; SEXUAL BEHAVIOR; WOMEN'S HEALTH;

EID: 33750060084     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. UNAIDS and WHO. AIDS Epidemic Update: December 2004. Geneva: UNAIDS, 2004.
2. Centers for Disease Control and Prevention. Revision of the case definition of acquired immunodeficiency syndrome for national reporting - United States. Morb Mortal Wkly Rep 1985; 34: 373-5.
3. Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition of acquired immunodeficiency syndrome. Morb Mort Wkly Rep 1987; 36 (Suppl): S1-S15.
4. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mort Wkly Rep 1992; 41 (RR-17): 1-19.
5. WHO. The work of WHO in the Eastern Mediterranean Region. Annual report of the regional director 1 January-31 December 2003. Cairo: World Health Organization Regional Office for the Eastern Mediterranean, 2004.
6. Pieniazek D, Baggs J, Hu DJ et al. Introduction of HIV-2 and multiple HIV-1 subtypes to Lebanon. Emerg Infect Dis 1998 (4): 649-56.
7. Mokhbat JE, Ibrahim N, Abdelkarim F, Kuleilat-Shatila M, Salem Z. The acquired immunodeficiency syndrome: report of the first case in Lebanon and review of the literature. J Med Liban 1985; 35: 295-311.
8. Centers for Disease Control and Prevention. Update: Impact of the expanded AIDS surveillance case distribution of adolescents and adults on case reporting - United States, 1993. Morb Mort Wkly Rep 1994; 43: 160-1, 167-70.
9. Naman RE, Mokhbat JE, Farah AE et al. Seroepidemiology of the human immunodeficiency virus in Lebanon: Preliminary evaluation. J Med Liban 1989; 38 (1): 5-8.
10. Kim JY. HIV/AIDS in the Eastern Mediterranean: a false immunity? East Mediterr Health J 2002; 8 (6): 684-8.
11. WHO. Best practice in HIV/AIDS prevention and care for injecting drug abusers. The triangular clinic in Kermanshah, Islamic Republic of Iran. Cairo: World Health Organization Regional Office of the Eastern Mediterranean, 2004.
12. Mokhbat JE, Naman RE, Rahme FS et al. Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons. J Med Liban 1989; 38 (1): 9-14.
13. FDA Approves First Nucleic Acid Test (NAT) System to screen whole blood donors for infection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Available at: www.fda.gov/bbs/topics/ANSWER/2002/ANS01140.html
14. Yeni PG, Hammer SM, Carpenter CC et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society - USA Panel. JAMA 2002; 288: 222-35.
15. European guidelines for the clinical management and treatment of HIV-infected adults in Europe. AIDS 2003; 17 (Suppl 2): S3-S26.